Dexcom Inc financial data

Symbol
DXCM on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
6340 Sequence Drive, San Diego, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 18, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 226 % -9.5%
Quick Ratio 28.7 % +11.4%
Debt-to-equity 198 % +3.91%
Return On Equity 29.6 % +71.5%
Return On Assets 8.82 % +2.68%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 391M shares +1.36%
Common Stock, Shares, Outstanding 391M shares +1.38%
Entity Public Float 45.3B USD -8.3%
Weighted Average Number of Shares Outstanding, Basic 394M shares +1.97%
Weighted Average Number of Shares Outstanding, Diluted 413M shares -3.01%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 4.03B USD +11.3%
Research and Development Expense 552M USD +9.21%
Operating Income (Loss) 600M USD +0.39%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 709M USD -0.2%
Income Tax Expense (Benefit) 133M USD -21.4%
Net Income (Loss) Attributable to Parent 576M USD +6.41%
Earnings Per Share, Basic 1.46 USD/shares +4.29%
Earnings Per Share, Diluted 1.42 USD/shares +9.23%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 606M USD +7.03%
Accounts Receivable, after Allowance for Credit Loss, Current 1.01B USD +3.27%
Inventory, Net 543M USD -3.04%
Other Assets, Current 39.7M USD -19.5%
Assets, Current 4.3B USD -2.81%
Deferred Income Tax Assets, Net 481M USD +14.7%
Property, Plant and Equipment, Net 1.08B USD +25.6%
Operating Lease, Right-of-Use Asset 62.8M USD -12%
Intangible Assets, Net (Excluding Goodwill) 103M USD -23.1%
Goodwill 22.8M USD -9.52%
Other Assets, Noncurrent 173M USD +131%
Assets 6.48B USD +3.51%
Employee-related Liabilities, Current 112M USD -34.5%
Contract with Customer, Liability, Current 8M USD -56.5%
Liabilities, Current 2.93B USD +88.4%
Contract with Customer, Liability, Noncurrent 9.5M USD +28.4%
Deferred Income Tax Liabilities, Net 4.6M USD -13.2%
Operating Lease, Liability, Noncurrent 65M USD -18.9%
Other Liabilities, Noncurrent 148M USD +17.8%
Liabilities 4.38B USD +4.43%
Accumulated Other Comprehensive Income (Loss), Net of Tax -8M USD +52.1%
Retained Earnings (Accumulated Deficit) 1.6B USD +56.4%
Stockholders' Equity Attributable to Parent 2.1B USD +1.64%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 2.1B USD +1.64%
Liabilities and Equity 6.48B USD +3.51%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 209M USD +34.6%
Net Cash Provided by (Used in) Financing Activities 4.7M USD -58%
Net Cash Provided by (Used in) Investing Activities 74.8M USD
Common Stock, Shares Authorized 800M shares 0%
Common Stock, Shares, Issued 409M shares +0.42%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 285M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 607M USD +7.01%
Deferred Tax Assets, Valuation Allowance 222M USD -16%
Deferred Tax Assets, Gross 748M USD +0.92%
Operating Lease, Liability 87.5M USD -13.5%
Payments to Acquire Property, Plant, and Equipment 56.9M USD -23.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 585M USD +9.04%
Lessee, Operating Lease, Liability, to be Paid 99.5M USD -15.6%
Property, Plant and Equipment, Gross 1.47B USD +31.1%
Operating Lease, Liability, Current 22.5M USD +6.64%
Lessee, Operating Lease, Liability, to be Paid, Year Two 26.1M USD +6.53%
Lessee, Operating Lease, Liability, to be Paid, Year One 26.8M USD +1.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) -41.8M USD -349%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 12M USD -28.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 20.9M USD -14.3%
Deferred Tax Assets, Operating Loss Carryforwards 14.4M USD -20.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 66.2M USD +11.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 15.9M USD -17.2%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 8.1M USD +8%
Depreciation, Depletion and Amortization 52.5M USD +26.2%
Deferred Tax Assets, Net of Valuation Allowance 526M USD +10.3%
Share-based Payment Arrangement, Expense 170M USD +13%
Interest Expense 20.3M USD +9.14%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%